Multiple Skleroz’lu Hastalarda Üst Ekstremite Ataksisinin Bilgisayar Analizi İle Değerlendirilmesi

• Main Authors: Fatma Erdeo, Kadriye Armutlu, Ali Ulvi Uca, İbrahim Yıldız
• Format: Article
• Language: English
• Published: Dicle University Medical School 2017-09-01
• Series: Dicle Medical Journal
• Subjects: Multipl Sclerosis; upperlimb; ataxia
• Online Access: http://diclemedj.org/upload/sayi/65/Dicle%20Med%20J-03283.PDF

Objective: Neurological and neurophysiologic disorders such as Multiple Sclerosis (MS) and disorders with disabilities need to be evaluated thoroughly and thoroughly. In MS we developed a new test (Multiple Sclerosis Ataxia Test) (MSAT) to evaluate the upper extremity coordination problem. This test provides a computer-based evaluation platform to fully assess the severity of the upper extremity coordination problem. Method: (MSAT) was tested on 23 patients (MS) with 18 MS in EDSS groups with different (Expanded Disability Status Scale) MS disease. The amount of deviation of the following patient by the spiral line pen on the tablet is given as a percentage. Since the same practices were applied in healthy group, dominant and non dominant hand were compared in MS and healthy group. Results The Ataxia Ratio Scale (UAQ) was compared with the upper extremity kinetic functions section. Findings: No statistically significant correlation was found between EDSS and patients' dominant hand (right h and). (p>0.05). There was no significant correlation between ICAR variance and dominant and non-dominant hand (p>0.05). There was a statistically significant difference between the two groups in the analysis of right hand comparison of patients and healthy subjects (p<0.05). Conclusion: MSAT evaluates upper extremity ataxia more objectively and can give information about the functional status of the patient before and after treatment. This method may have the same transformative effect on clinical evaluation and research in MS, as does standardized computerized tests in the field of education, which have a clear potential to accelerate progress in clinical evaluation and research.